除了动脉输血法正处于临床试验中，全血的应用管理也遵循了血浆和白蛋白的模式。
The administration of whole blood also followed the same pattern except that intra-arterial transfusion was given a trial.
全血检查，包括血小板计数、纤维蛋白原水平、部分凝血活酶时间、ABO血型和抗体监测。
CBC with platelet count, fibrinogen level, partial thromboplastin time, and ABO blood typing and antibody screen are obtained.
两组于治疗前、后分别采静脉血检测血浆纤维蛋白原、红细胞压积、全血粘度和血浆粘度的变化。
Venous blood samples were taken respectively in the two groups to detect the changes of plasma fibrinogen, hematocrit, whole blood viscosity and plasma viscosity.
术后血浆纤维结合蛋白的减少和术中丢失含有纤维结合蛋白的全血及术后大量消耗纤维结合蛋白有关。
The postoperative decrease of FN was related to the loss of whole blood containing FN in operation and to the consumption of large amount of FN after operation.
还分别测定了全血黏度、浆黏度、细胞聚集指数(IRC)纤维蛋白原及血小板聚集率。
Blood viscosity, plasma viscosity, aggregation index of RBC (AIRC) and fibrinogen were also assayed respectively.
结果脂肪肝患者的全血高切黏度、中切黏度、低切黏度、血浆黏度、红细胞聚集指数和纤维蛋白原均高于非脂肪肝人员（P〈0.01）。
Results All the values of whole blood viscosity, plasma viscosity, red cell aggregation index and plasma fibrinogen of the patients with fatty liver were higher than those of healthy people(P0.01).
结论：降纤酶治疗急性脑梗死疗效确切，能显著降低纤维蛋白原，改善全血黏度，降低致残率，不良反应少。
Conclusion: Defibrase can significantly decrease fibrinogen, improve whole blood viscosity, and decrease disability rate. With little side effect, it is effective on acute cerebral infarction.
结果：发现ION组全血黏度、血浆度、红细胞电泳时间及血浆纤维蛋白原含量增高，与对照组差别显著（P< 0 .0 5 ，P< 0 .0 1 ）。
Results: There was significant differences in blood viscosity, plasma viscosity, erythrocyte electrophoresis time and fibrinogen level between ION group and matched control (P<0.05, P<0.01).
结果：发现ION组全血黏度、血浆度、红细胞电泳时间及血浆纤维蛋白原含量增高，与对照组差别显著（P< 0 .0 5 ，P< 0 .0 1 ）。
Results: There was significant differences in blood viscosity, plasma viscosity, erythrocyte electrophoresis time and fibrinogen level between ION group and matched control (P<0.05, P<0.01).
应用推荐